Healthtech Series A Investors & VC Firms

2210 firms in this list, with a median first check of $500K. 526 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
AN Angaza Capital AH1 person	88🔒	Abu Dhabi	AE	Seed–Growth	—	+ Add to CRM
CI City Hill Ventures JE1 person · Leads rounds	88🔒	San Diego	US	Seed–Series A	$100K – $20M	+ Add to CRM
HE HealthCare Ventures, LLC AL1 person	88🔒	Cambridge	US	Series A–Late Stage	$1M – $20M	+ Add to CRM
IS Israel Innovation Authority SR1 person	88🔒	Jerusalem	IL	Pre-Seed–Growth	$140K – $5M	+ Add to CRM
MI Mint Ventures GF1 person · Leads rounds	88🔒	Scotland	GB	Pre-Seed–Series A	$63K – $252K	+ Add to CRM
RD RDF Ventures MC1 person · Follows rounds	88🔒	Vermont	US	Pre-Seed–Series A	$100K – $250K	+ Add to CRM
EM Empirical Ventures BMDBDJJM4 people	88🔒	London	GB	Pre-Seed–Series A	—	+ Add to CRM
FO Fortitude Ventures SCBYICRL4 people	88🔒	San Francisco Bay Area	US	Pre-Seed–Series A	—	+ Add to CRM
GO Good Group IFSBALMG4 people	88🔒	Tel Aviv	IL	Pre-Seed–Series A	—	+ Add to CRM
MA Majuven LHLTLYHK4 people	88🔒	Singapore	SG	Seed–Late Stage	—	+ Add to CRM
SO South China Venture Capital JWWHXLYW4 people	88🔒	Shenzhen	CN	Seed–Late Stage	—	+ Add to CRM
CO Cornucopian Capital Management	88🔒	Montclair	US	Pre-Seed–Series A	—	+ Add to CRM
EM Emkan Capital	88🔒	Riyadh	SA	Pre-Seed–Series A	$1.2M – $20M	+ Add to CRM
RE Reverent Partners Leads rounds	88🔒	Seoul	KR	Series A–Late Stage	—	+ Add to CRM
SW Swedfund International AB	88🔒	Stockholm	SE	Series A–Growth	$3M – $10M	+ Add to CRM
18 1855 Capital Partners MRM2 people	88🔒	State College	US	Seed–Series A	$100K – $500K	+ Add to CRM
AN another.vc FHMS2 people · Follows rounds	88🔒	Mülheim an der Ruhr	DE	Pre-Seed–Series A	$270K	+ Add to CRM
TA Tarnagulla Ventures NMWM2 people	88🔒	Melbourne	AU	Pre-Seed–Series A	—	+ Add to CRM
AM Amgen Ventures RK1 person	88🔒	Thousand Oaks	US	Seed–Late Stage	$1M – $3M	+ Add to CRM
AY AYANA Capital LLC AK1 person	88🔒	Tampa	US	Pre-Seed–Series A	$1M – $3M	+ Add to CRM
BE Belal Badat Ventures MB1 person	88🔒	Dallas	US	Pre-Seed–Growth	$300K – $500K	+ Add to CRM
BL BlueHub Capital ED1 person	88🔒	Boston	US	Seed–Series A	$250K – $1.5M	+ Add to CRM
CR Crossover VC NL1 person · Follows rounds	88🔒	Los Angeles	US	Pre-Seed–Series A	$1M	+ Add to CRM
FI Finnish Fund for Industrial Cooperation Ltd. (FINNFUND) OS1 person	88🔒	Helsinki	FI	Seed–Growth	$2.7M – $135M	+ Add to CRM

Angaza Capital

Abu DhabiSeed–Growth

AH1 person

City Hill Ventures

San DiegoSeed–Series A$100K – $20M

JE1 person

HealthCare Ventures, LLC

CambridgeSeries A–Late Stage$1M – $20M

AL1 person

Israel Innovation Authority

JerusalemPre-Seed–Growth$140K – $5M

SR1 person

Mint Ventures

ScotlandPre-Seed–Series A$63K – $252K

GF1 person

RDF Ventures

VermontPre-Seed–Series A$100K – $250K

MC1 person

Empirical Ventures

LondonPre-Seed–Series A

BMDBDJJM4 people

Fortitude Ventures

San Francisco Bay AreaPre-Seed–Series A

SCBYICRL4 people

Good Group

Tel AvivPre-Seed–Series A

IFSBALMG4 people

Majuven

SingaporeSeed–Late Stage

LHLTLYHK4 people

South China Venture Capital

ShenzhenSeed–Late Stage

JWWHXLYW4 people

Cornucopian Capital Management

MontclairPre-Seed–Series A

Emkan Capital

RiyadhPre-Seed–Series A$1.2M – $20M

Reverent Partners

SeoulSeries A–Late Stage

Swedfund International AB

StockholmSeries A–Growth$3M – $10M

1855 Capital Partners

State CollegeSeed–Series A$100K – $500K

MRM2 people

another.vc

Mülheim an der RuhrPre-Seed–Series A$270K

FHMS2 people

Tarnagulla Ventures

MelbournePre-Seed–Series A

NMWM2 people

Amgen Ventures

Thousand OaksSeed–Late Stage$1M – $3M

RK1 person

AYANA Capital LLC

TampaPre-Seed–Series A$1M – $3M

AK1 person

Belal Badat Ventures

DallasPre-Seed–Growth$300K – $500K

MB1 person

BlueHub Capital

BostonSeed–Series A$250K – $1.5M

ED1 person

Crossover VC

Los AngelesPre-Seed–Series A$1M

NL1 person

Finnish Fund for Industrial Cooperation Ltd. (FINNFUND)

HelsinkiSeed–Growth$2.7M – $135M

OS1 person

Data sourced from public filings and firms' own websites — see our methodology.